Technical pitfalls potentially affecting diagnoses in immunohistochemistry.
about
Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysisSimultaneous Detection of EGFR and VEGF in Colorectal Cancer using Fluorescence-Raman Endoscopy.Prognostic factors in resected lung carcinomas.Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box.CB2: a cannabinoid receptor with an identity crisisMRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.Standardization of negative controls in diagnostic immunohistochemistry: recommendations from the international ad hoc expert panel.Non-specific immunostaining by a rabbit antibody against gustducin α subunit in mouse brainBeyond H&E: integration of nucleic acid-based analyses into diagnostic pathology.Application of alternative fixatives to formalin in diagnostic pathology.Disaccharides Protect Antigens from Drying-Induced Damage in Routinely Processed Tissue Sections.Microfluidic processor allows rapid HER2 immunohistochemistry of breast carcinomas and significantly reduces ambiguous (2+) read-outs.Optimized Protocol of Methanol Treatment for Immunofluorescent Staining in Fixed Brain Slices.Verification of the Cross Immunoreactivity of A60, a Mouse Monoclonal Antibody against Neuronal Nuclear Protein.Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancerEarly-onset colorectal cancer patients without family history are "at very low risk" for lynch syndrome.Endoscopic ultrasound-guided fine-needle aspiration of intrathoracic and intra-abdominal spindle cell and mesenchymal lesions.Personalized medicine for lung cancer: new challenges for pathology.Targeting CD30 in malignant tissues: challenges in detection and clinical applications.Latest biopsy approach for suspected metastases in patients with breast cancer.A method for histopathological study of the multifocal nature of spinal cord lesions in murine experimental autoimmune encephalomyelitis.BMTP-11 is active in preclinical models of human osteosarcoma and a candidate targeted drug for clinical translation.Non-specific binding of antibodies in immunohistochemistry: fallacies and facts.Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application scheduleICSH guidelines for the standardization of bone marrow immunohistochemistry.Comparison of Different Decalcification Methods Using Rat Mandibles as a Model.Receptor Conversion in Distant Breast Cancer Metastases: A Systematic Review and Meta-analysis.Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.A modular design of low-background bioassays based on a high-affinity molecular pair barstar:barnase.A New Paradigm for Tissue Diagnostics: Tools and Techniques to Standardize Tissue Collection, Transport, and Fixation.Impact of Decalcification on Receptor Status in Breast Cancer
P2860
Q26769728-FD5CD073-65C4-4F46-AC00-387F65DC66B8Q30850627-5B28A630-01FD-48BD-B25A-9209D573100BQ33697964-0BE8FD28-6C32-4504-A7E1-FB5FE9F2D4F6Q33876854-8B70ADFB-DCEA-4DB9-AD95-3419C61250CBQ34098185-1B8A18EF-B9A4-4262-8A39-6F3A6353092AQ34138714-34DFD49E-870B-49D7-B4C3-5E467B31686CQ34388880-5F91C673-D8D0-47BE-A236-544CB8746DD8Q35009800-93071D47-A9B3-48A6-A4B9-5B617E945CCEQ35017911-5608D66A-214B-4EF6-A664-3B751322F719Q36193598-9E9024AF-B308-4622-ABB3-1A85F38DA1F9Q36737112-CA4B2923-85BD-49EF-ACC5-17CCCBEEC1F2Q36747714-92299E0D-A2FD-4F17-9E96-C04E7A7095AEQ36844850-BE9E81F3-6589-4B77-8329-9EB5EF13CDB9Q36897344-3FA3EF17-BEB3-4A86-9308-585298F69043Q37240839-616F93A8-FF8F-47BE-BC0D-AF1D03BAF39AQ37479736-AEBA089E-ED45-407E-A3DF-B0F7DCB836ECQ37802310-B5E8C82A-C2FE-41AE-8EC2-D9BA254D4534Q37932029-91B4E66B-62E6-4A9B-9449-C92F52FF6D02Q38108134-C4877F35-5A73-47BE-B07D-3F3B43738863Q38154494-6FADE571-6474-42E5-A2FA-0CF01B31346BQ38258366-454E6787-BD71-4B1C-86B8-161AECD4FD2FQ38683340-20CD5BFB-BD83-4985-9EE6-53979A06B8B5Q39119418-5FAD28EA-3323-499D-9446-ABEE757A56C6Q39358414-C4C0AA98-3DB4-4960-9491-9DB5EEACA902Q46201774-C763DAB4-964B-4C33-9D22-39715D9826D6Q48275368-5BE63D1E-0643-4132-A608-77EEA55357E7Q50120368-195782FE-4A25-471F-A28F-4D1DC04648CFQ53140967-CB86EEDD-D51F-4F64-9A7A-A2A28ADE460AQ54316071-988CECD1-D8C2-46C5-AC90-D0F721E9660DQ55322794-8B0BF16B-A2EA-436F-ABBB-AA6028D82518Q57385825-65620A17-65AA-4B9F-B18B-69A1B12D677F
P2860
Technical pitfalls potentially affecting diagnoses in immunohistochemistry.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Technical pitfalls potentially affecting diagnoses in immunohistochemistry.
@en
Technical pitfalls potentially affecting diagnoses in immunohistochemistry.
@nl
type
label
Technical pitfalls potentially affecting diagnoses in immunohistochemistry.
@en
Technical pitfalls potentially affecting diagnoses in immunohistochemistry.
@nl
prefLabel
Technical pitfalls potentially affecting diagnoses in immunohistochemistry.
@en
Technical pitfalls potentially affecting diagnoses in immunohistochemistry.
@nl
P356
P1476
Technical pitfalls potentially affecting diagnoses in immunohistochemistry.
@en
P2093
E Leonardo
G Bussolati
P304
P356
10.1136/JCP.2007.047720
P407
P577
2008-03-06T00:00:00Z